It's been a while. The Corti team has been working very hard on a novel delivery system: scLNP, which enables precision and broad access to the exact disease associated tissues/cells. I am heading to ASGCT at Baltimore. I look forward to (re)connecting to colleagues and exchanging thoughts there, so that we can collectively bring the best medicines to patients.
关于我们
Corti Therapeutics is a seed-stage biotechnology company focusing on developing the next generation of lipid nanoparticle technology for selective and efficient extrahepatic delivery. Our technology has tunable cell selectivity and high developability. We are founded by industry leaders.
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 类型
- 私人持股